Find the latest oncology news for your sub-specialty area
Ludwig Cancer Research scientists have devised new types of chimaeric antigen-receptor (CAR) T cells—a type…
Dermatofibrosarcoma protuberans (DFSP) is a rare skin sarcoma known for its high recurrence rates, making…
Antibody-drug conjugates (ADCs) have emerged as a promising approach in cancer therapy, offering a ‘magic…
Drugs designed to target HER2-positive breast cancer could also benefit some patients with bile duct…
Scientists have created a 3D-printed model to mimic the specific conditions that spur the spread…
Scientists at the Agency for Science, Technology and Research (A*STAR) along with collaborators from the…
Researchers have shown that they can accurately re-create clinical trials of new treatments using ‘digital…
Researchers at The University of Texas at El Paso, USA, have created a portable device…
Researchers from The University of Texas MD Anderson Cancer Centre, USA, demonstrated that anti-PD-L1 immunotherapy in combination with mutation-directed targeted…
Glucagon-like peptide-1-receptor agonists (GLP-1RA) are medications that are increasingly prescribed for patients with type 2…